Psychosis
📧 Sign up to get email alerts when something new happens for Psychosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: Mindfulness, Group Therapy and Psychosis; Training Decreases Anxiety and Depression
A completed clinical trial examining mindfulness, group therapy, and training to reduce anxiety and depression in individuals with psychosis…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2) [Phase 3]
Phase 3 study EMERGENT-2 evaluating KarXT for acutely psychotic hospitalized adults with schizophrenia has completed; results were posted in…
-
CLINICAL_TRIALS trial_result · 2023-09-29Clinical Trial Update: Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis [Phase 4]
Phase 4 clinical trial update exploring multidisciplinary design to optimize schizophrenia treatment using multi-omics data and systems biol…
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology
Clinical trial completed examining the impact of COVID-19 on psychopathology, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-04-24Clinical Trial Update: Cognitive Behavioral Suicide Prevention for Psychosis: Aim 1 [NA]
Completed clinical trial evaluating cognitive behavioral suicide prevention for individuals with psychosis; results posted in 2023.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: Pilot Study of Motivational Interviewing for Loved Ones [NA]
Pilot study evaluating motivational interviewing for loved ones of individuals with psychotic disorders; study completed with results posted…
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes [NA]
Clinical trial update on CBT-I for psychosis reports guidelines, preliminary efficacy, and functional outcomes for insomnia and psychosis, w…
-
CLINICAL_TRIALS trial_result · 2022-11-21Clinical Trial Update: Levetiracetam in Early Psychosis [Phase 2]
Phase 2 trial update evaluating levetiracetam in early psychosis has been completed with results posted in 2022.
-
FDA approval · 2022-11-18FDA Approved: HALOPERIDOL — Original Application (Novadoz Pharmaceuticals LLC)
FDA approves the original application for HALOPERIDOL, a generic product manufactured by Novadoz Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Families With Substance Use and Psychosis: A Pilot Study [NA]
A completed pilot study from McLean Hospital investigating families with substance use and psychosis; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: Non-Invasive Direct Current Stimulation for Cognition in Schizophrenia [NA]
A terminated clinical trial investigating non-invasive direct current stimulation for cognition in schizophrenia/psychosis; results posted i…
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis [Phase 1, Phase 2]
A placebo-controlled study of IV ceftriaxone for refractory psychosis was terminated; results were posted in 2022.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Improving Adherence to Cognitive Rehabilitation [NA]
Clinical trial update on improving adherence to cognitive rehabilitation for psychosis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-05Clinical Trial Update: Pharmacologic Modulation of Hippocampal Activity in Psychosis [Phase 2]
Phase 2 trial investigating pharmacologic modulation of hippocampal activity in schizophrenia/psychosis; study terminated with posted result…
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients [Phase 4]
Phase 4 trial update on adjunctive use of flupentixol (Fute) in patients with schizophrenia treated with multi-acting receptor-targeted anti…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression [Phase 2]
Phase 2 clinical trial of MP-101 in dementia-related psychosis and agitation/aggression was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: Prefrontal Cortical Engagement Through Non-Invasive Brain Stimulation in Schizophrenia [NA]
Completed clinical trial investigating non-invasive brain stimulation to engage prefrontal cortex in schizophrenia/psychosis; results posted…
-
CLINICAL_TRIALS trial_result · 2020-05-19Clinical Trial Update: NAPLS Omega-3 Fatty Acid Versus Placebo Study [Phase 1]
Phase 1 trial update evaluating omega-3 fatty acids versus placebo for psychosis has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-05-14Clinical Trial Update: Effect Evaluation of Individual Placement and Support (IPS) [NA]
Clinical trial update reporting completion and results posting for an IPS-based evaluation in psychosis and substance abuse populations.
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Clozapine Versus Olanzapine as Treatment for Comorbid Psychotic Disorder and Substance Use Disorder [Phase 4]
Phase 4 clinical trial comparing clozapine and olanzapine for patients with comorbid psychotic disorder and substance use disorder; status u…
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up [Phase 4]
Phase 4 clinical trial update assessing neurocognitive effectiveness in treatment of first-episode non-affective psychosis with a 3-year fol…
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: Minocycline and/or Omega-3 Fatty Acids Added to Treatment as Usual for At Risk Mental States [Phase 2]
Phase 2 trial evaluating minocycline and/or omega-3 fatty acids added to treatment as usual for individuals at risk of psychosis or with ARM…
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up [Phase 4]
A Phase 4 clinical trial update evaluating the long-term effectiveness of second generation antipsychotics in patients with first-episode ps…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Mindfulness-based Social Cognition Training for Psychosis (SocialMind): A Feasibility Study [NA]
This update reports the completion of a feasibility trial of Mindfulness-based Social Cognition Training (SocialMind) for schizophrenia and …
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Glutamate, Brain Connectivity and Duration of Untreated Psychosis
This update reports the completion of a clinical trial examining glutamate-related brain connectivity and the duration of untreated psychosi…